Table of Contents FDA Approves Lisdexamfetamine for the Treatment of Depression Resources and References: Drug firm Alembic Pharmaceuticals NSE 0.07 % on Monday said it had received a final nod from US health regulator for Vilazodone Hydrochloride tablets used for the treatment of depression. AlembicNSE – 0.29 % said in a filing to BSE that…
Table of Contents Latest News and Details on MS Contin Addiction, Abuse and Detox Prevalence of Contin Abuse and Addiction Symptoms of Contin Withdrawal References and Resources Latest News and Details on MS Contin Addiction, Abuse and Detox Morphine is a non-synthetic prescription opioid drug that many other narcotics are modeled off or made from.…
Table of Contents NewsReports On Increase Of Lyrica Addiction And Overdose death Cases. References and Resources News Reports On Increase of Lyrica Addiction and Overdose Death Cases On the back of public consultation and advice from the Advisory Council on the Misuse of Drugs, Lyrica is known on the street as ‘buds’ and has now…
Table of Contents News And Facts:Luminal Use, Abuse, Addiction and Side Effects What Is Luminal Used For? Information On Luminal Addiction Signs References and Resources News And Facts :Luminal Use, Abuse, Addiction and Side Effects There has been a considerable increase in prescription drug abuse and addiction during the past decade. Prescription drug misuse can…
Table of Contents Reports On Ludiomil Use and Addiction Ludiomil Usage Ways Of Preventing Ludiomil Addiction Side Effects of Ludiomil Use and Abuse References and Resources Reports On Ludiomil Use and Addiction Antidepressant medications are used to treat various conditions, including depression and other mental and mood disorders. These medications can help prevent suicidal thoughts…
Table of Contents Kadian Use and Addiction News: FDA Regulations, Abuse and Effects References and Resources The FDA approved generic equivalents of the Kadian®, a product brand name, in November 2011. The drug is an extended-release morphine product manufactured by Actavis Elizabeth LLC. Even though the commercial introduction of a new generic formulation is perhaps…
Table of Contents Classification of Hydrocodone as a Schedule II Drug Updates On Changes in Hydrocodone Prescribing Practices Hydrocodone Addiction News Reports On Signs of Success References and Resources Classification of Hydrocodone as a Schedule II Drug In October 2014, The DEA changed hydrocodone combination analgesics from Schedule III of the Controlled Substances Act to…
[fusion_builder_container hundred_percent=”no” hundred_percent_height=”no” hundred_percent_height_scroll=”no” hundred_percent_height_center_content=”yes” equal_height_columns=”no” menu_anchor=”” hide_on_mobile=”small-visibility,medium-visibility,large-visibility” status=”published” publish_date=”” class=”” id=”” border_size=”” border_color=”” border_style=”solid” margin_top=”” margin_bottom=”” padding_top=”” padding_right=”” padding_bottom=”” padding_left=”” gradient_start_color=”” gradient_end_color=”” gradient_start_position=”0″ gradient_end_position=”100″ gradient_type=”linear” radial_direction=”center center” linear_angle=”180″ background_color=”” background_image=”” background_position=”center center” background_repeat=”no-repeat” fade=”no” background_parallax=”none” enable_mobile=”no” parallax_speed=”0.3″ background_blend_mode=”none” video_mp4=”” video_webm=”” video_ogv=”” video_url=”” video_aspect_ratio=”16:9″ video_loop=”yes” video_mute=”yes” video_preview_image=”” filter_hue=”0″ filter_saturation=”100″ filter_brightness=”100″ filter_contrast=”100″ filter_invert=”0″ filter_sepia=”0″ filter_opacity=”100″ filter_blur=”0″…
Table of Contents The FDA and OPDP Warns Galt Pharmaceuticals LLC about Doral Marketing Practices References and Resources The FDA and OPDP Warns Galt Pharmaceuticals LLC about Doral Marketing Practices The US Food and Drug Administration (FDA), and the Office of Prescription Drug Promotion (OPDP) sent a Warning Letter to Galt Pharmaceuticals LLC concerning its…
New research published in the Nature journal Scientific Reports investigated Ohio Health Department records from 2010 to 2017. They observed that white men between the ages of 30 and 39 were most at risk of lethal overdoses. The epidemic disproportionately affects white men over white women in all age categories, the study found.The study found…
